(Q38446357)

English

Evolution in the understanding of the pathophysiological basis of portal hypertension: How changes in paradigm are leading to successful new treatments

scientific article published on April 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

3 September 2017

1 reference

Europe PubMed Central

Evolution in the understanding of the pathophysiological basis of portal hypertension: How changes in paradigm are leading to successful new treatments (English)

1 reference

Europe PubMed Central

PMC publication ID

3 September 2017

pathophysiology

1 reference

based on heuristic

inferred from title

portal hypertension

1 reference

based on heuristic

inferred from title

author name string

Jaume Bosch

1

1 reference

Europe PubMed Central

PMC publication ID

3 September 2017

Roberto J Groszmann

2

1 reference

Europe PubMed Central

PMC publication ID

3 September 2017

Vijay H Shah

3

1 reference

Europe PubMed Central

PMC publication ID

3 September 2017

publication date

1 April 2015

1 reference

Europe PubMed Central

PMC publication ID

3 September 2017

Journal of Hepatology

1 reference

Europe PubMed Central

PMC publication ID

3 September 2017

62

1 reference

Europe PubMed Central

PMC publication ID

3 September 2017

1 Suppl

1 reference

Europe PubMed Central

PMC publication ID

3 September 2017

S121-30

1 reference

Europe PubMed Central

PMC publication ID

3 September 2017

Chronic passive venous congestion drives hepatic fibrogenesis via sinusoidal thrombosis and mechanical forces.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

6 September 2017

Liver sinusoidal endothelial cells in hepatic fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

6 September 2017

Molecular pathophysiology of portal hypertension.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

6 September 2017

Vascular pathobiology in chronic liver disease and cirrhosis - current status and future directions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

6 September 2017

Pharmacologic management of portal hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

6 September 2017

Inflammation and portal hypertension - the undiscovered country.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

6 September 2017

Vascular endothelial growth factor promotes fibrosis resolution and repair in mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

6 September 2017

Divergent angiocrine signals from vascular niche balance liver regeneration and fibrosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

6 September 2017

The burden of liver disease in Europe: a review of available epidemiological data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

6 September 2017

Fibronectin induces endothelial cell migration through β1 integrin and Src-dependent phosphorylation of fibroblast growth factor receptor-1 at tyrosines 653/654 and 766.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

6 September 2017

Intestinal decontamination inhibits TLR4 dependent fibronectin-mediated cross-talk between stellate cells and endothelial cells in liver fibrosis in mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

6 September 2017

Mechanisms of hepatic fibrogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

6 September 2017

Noninvasive assessment of portal hypertension in patients with cirrhosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

6 September 2017

Pathogenesis of liver fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

6 September 2017

Inductive angiocrine signals from sinusoidal endothelium are required for liver regeneration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

6 September 2017

Intrahepatic angiogenesis and sinusoidal remodeling in chronic liver disease: new targets for the treatment of portal hypertension?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

6 September 2017

A distinct nitric oxide and adenosine A1 receptor dependent hepatic artery vasodilatatory response in the CCl-cirrhotic liver

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

6 September 2017

Management of varices and variceal hemorrhage in cirrhosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

6 September 2017

Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

6 September 2017

The clinical use of HVPG measurements in chronic liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

6 September 2017

Angiogenesis in liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

6 September 2017

Liver cell-derived microparticles activate hedgehog signaling and alter gene expression in hepatic endothelial cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

6 September 2017

Sinusoidal endothelial cells prevent rat stellate cell activation and promote reversion to quiescence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

6 September 2017

TLR4 enhances TGF-beta signaling and hepatic fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

6 September 2017

Proangiogenic cytokines as hypoxia-dependent factors stimulating migration of human hepatic stellate cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

6 September 2017

Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

6 September 2017

Toll-like receptor signaling in the liver

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

6 September 2017

Reversal of hepatic fibrosis -- fact or fantasy?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

6 September 2017

Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

6 September 2017

Portal hypertension: from bedside to bench.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

6 September 2017

The cardiac output at rest in Laennec's cirrhosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

6 September 2017

Current management of portal hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

6 September 2017

The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

6 September 2017

Gene transfer of the neuronal NO synthase isoform to cirrhotic rat liver ameliorates portal hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

6 September 2017

Liver sinusoidal endothelial cells are responsible for nitric oxide modulation of resistance in the hepatic sinusoids

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

6 September 2017

Expression of variant fibronectins in wound healing: cellular source and biological activity of the EIIIA segment in rat hepatic fibrogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

6 September 2017

Hepatic artery flow improvement after portacaval shunt: a single hemodynamic clinical correlate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

14 September 2017

Determination of the hepatic arterial blood flow and oxygen supply in man by clamping the hepatic artery during surgery

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

14 September 2017

Activation-dependent contractility of rat hepatic lipocytes in culture and in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

14 September 2017

Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

14 September 2017

Portal Blood Flow in Cirrhosis of the Liver*

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

14 September 2017

Adenosine as putative regulator of hepatic arterial flow (the buffer response).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

27 September 2017

Disruption of negative feedback loop between vasohibin-1 and vascular endothelial growth factor decreases portal pressure, angiogenesis, and fibrosis in cirrhotic rats.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

23 June 2018

Endothelial cell toll-like receptor 4 regulates fibrosis-associated angiogenesis in the liver

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

23 June 2018

Increased blood flow through the portal system in cirrhotic rats.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

23 June 2018

Circulation times in the splanchnic and hepatic beds in alcoholic liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

23 June 2018

Reduction of the increased portal vascular resistance of the isolated perfused cirrhotic rat liver by vasodilators.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

23 June 2018

Compensatory mechanisms in response to an elevated hepatic oxygen consumption in chronically ethanol-fed rats.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

23 June 2018

Evolution of portal hypertension and mechanisms involved in its maintenance in a rat model.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

23 June 2018

HMGB1 recruits hepatic stellate cells and liver endothelial cells to sites of ethanol-induced parenchymal cell injury

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

31 August 2018

Activation of the MAS receptor by angiotensin-(1-7) in the renin-angiotensin system mediates mesenteric vasodilatation in cirrhosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

31 August 2018

Terutroban, a TP-receptor antagonist, reduces portal pressure in cirrhotic rats.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

31 August 2018

The transcription factor KLF2 mediates hepatic endothelial protection and paracrine endothelial-stellate cell deactivation induced by statins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

31 August 2018

Atorvastatin attenuates hepatic fibrosis in rats after bile duct ligation via decreased turnover of hepatic stellate cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

31 August 2018

Carvedilol for portal hypertension in patients with cirrhosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

31 August 2018

Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

31 August 2018

Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

31 August 2018

Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

31 August 2018

Superoxide dismutase gene transfer reduces portal pressure in CCl4 cirrhotic rats with portal hypertension.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

31 August 2018

Nitric oxide and vascular remodeling modulate hepatic arterial vascular resistance in the isolated perfused cirrhotic rat liver

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

31 August 2018

The role of hepatic arterial flow on portal venous and hepatic venous wedged pressure in the isolated perfused CCl4-cirrhotic liver

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

31 August 2018

Ascorbic acid improves the intrahepatic endothelial dysfunction of patients with cirrhosis and portal hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

31 August 2018

Rat liver sinusoidal endothelial cell phenotype is maintained by paracrine and autocrine regulation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

31 August 2018

Anti-VEGF receptor-2 monoclonal antibody prevents portal-systemic collateral vessel formation in portal hypertensive mice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

31 August 2018

Simvastatin enhances hepatic nitric oxide production and decreases the hepatic vascular tone in patients with cirrhosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

31 August 2018

Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

31 August 2018

Cyclooxygenase-derived products modulate the increased intrahepatic resistance of cirrhotic rat livers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

31 August 2018

5-lipoxygenase inhibition reduces intrahepatic vascular resistance of cirrhotic rat livers: a possible role of cysteinyl-leukotrienes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

31 August 2018

Administration of N omega-nitro-L-arginine ameliorates portal-systemic shunting in portal-hypertensive rats.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

31 August 2018

Hepatic and portal vein thrombosis in cirrhosis: possible role in development of parenchymal extinction and portal hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

31 August 2018

Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

31 August 2018

Enoxaparin Prevents Portal Vein Thrombosis and Liver Decompensation in Patients With Advanced Cirrhosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

3 December 2018

Abnormal Plasma Microparticles Impair Vasoconstrictor Responses in Patients With Cirrhosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

3 December 2018

Endoscopic measurement of variceal pressure in cirrhosis: correlation with portal pressure and variceal hemorrhage

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4519833

3 December 2018

Pharmacological reduction of portal pressure and long-term risk of first variceal bleeding in patients with cirrhosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25920081

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mild increases in portal pressure upregulate vascular endothelial growth factor and endothelial nitric oxide synthase in the intestinal microcirculatory bed, leading to a hyperdynamic state

1 reference

https://pubmed.ncbi.nlm.nih.gov/25920081

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anticoagulation in cirrhosis patients: what don't we know?

1 reference

https://pubmed.ncbi.nlm.nih.gov/25920081

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impaired endothelial nitric oxide synthase activity associated with enhanced caveolin binding in experimental cirrhosis in the rat

1 reference

https://pubmed.ncbi.nlm.nih.gov/25920081

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiotensin II induces contraction and proliferation of human hepatic stellate cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/25920081

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endoscopic assessment of variceal volume and wall tension in cirrhotic patients: effects of pharmacological therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/25920081

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/25920081

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Carvedilol, a new nonselective beta-blocker with intrinsic anti-alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25920081

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Propranolol--a medical treatment for portal hypertension?

1 reference

https://pubmed.ncbi.nlm.nih.gov/25920081

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The eNOS cofactor tetrahydrobiopterin improves endothelial dysfunction in livers of rats with CCl4 cirrhosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25920081

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Simvastatin treatment improves liver sinusoidal endothelial dysfunction in CCl4 cirrhotic rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/25920081

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/25920081

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hyperdynamic circulation of liver disease 40 years later: pathophysiology and clinical consequences

1 reference

https://pubmed.ncbi.nlm.nih.gov/25920081

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Microparticles and paracrine signaling in portal hypertension: crucial conversations or idle chat?

1 reference

https://pubmed.ncbi.nlm.nih.gov/25920081

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of haemorrhage on hepatic artery and portal vein flows in the anaesthetized cat

1 reference

https://pubmed.ncbi.nlm.nih.gov/25920081

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitation of portasystemic shunting from the splenic and mesenteric beds in alcoholic liver disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/25920081

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.JHEP.2015.01.003

1 reference

Europe PubMed Central

PMC publication ID

3 September 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

3 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

3 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38446357&oldid=1760213683"